Profile data is unavailable for this security.
About the company
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
- Revenue in INR (TTM)17.82bn
- Net income in INR3.48bn
- Incorporated1995
- Employees3.08k
- LocationPoly Medicure LtdPlot No.104-105 & 115-116 , Sector-59,HSIDC Industrial Area, Ballabgarh,FARIDABAD 121004IndiaIND
- Phone+91 1 292307000
- Fax+91 1 292307007
- Websitehttps://www.polymedicure.com/
More ▼
Mergers & acquisitions
| Acquired company | POLYMED:NSI since announced | Transaction value |
|---|---|---|
| Medistream SA | -32.92% | 36.75m |
| Pendracare International Bv | -37.15% | -- |
Data delayed at least 15 minutes, as of Feb 18 2026 10:17 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xunfei Healthcare Technology Co Ltd | 10.54bn | -1.01bn | 122.09bn | 928.00 | -- | 10.56 | -- | 11.58 | -0.7209 | -0.7209 | 7.52 | 8.25 | 0.4471 | 3.36 | 1.11 | 997,578.90 | -4.80 | -- | -11.06 | -- | 54.37 | -- | -10.73 | -- | 1.49 | -- | 0.3613 | -- | 31.98 | -- | 8.45 | -- | -- | -- |
| Sino Medical Sciences Technology Inc | 6.61bn | 385.17m | 122.11bn | 691.00 | 315.53 | 10.29 | -- | 18.46 | 0.0706 | 0.0706 | 1.21 | 2.17 | 0.385 | 1.63 | 42.71 | 729,533.10 | 1.69 | -5.65 | 2.05 | -6.45 | 63.92 | 63.65 | 4.40 | -21.72 | 1.71 | 2.66 | 0.2102 | -- | 33.64 | 1.03 | 103.78 | -55.92 | -17.21 | -- |
| HOB Biotech Group Corp Ltd | 5.08bn | 477.91m | 122.92bn | 529.00 | 252.83 | 11.16 | -- | 24.18 | 0.5838 | 0.5838 | 6.17 | 13.23 | 0.3938 | 1.50 | 7.30 | 732,482.30 | 3.70 | 7.24 | 4.41 | 8.64 | 57.87 | 64.53 | 9.40 | 16.21 | 1.07 | 14.22 | 0.0805 | 42.82 | 2.01 | 9.20 | -22.24 | -10.43 | 34.88 | -- |
| Shanghai Runda Medical Technology Co Ltd | 97.13bn | -2.07bn | 126.16bn | 3.14k | -- | 2.30 | -- | 1.30 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 33.08bn | 5.04bn | 128.19bn | 2.16k | 27.80 | 1.87 | -- | 3.87 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| Poly Medicure Ltd. | 17.82bn | 3.48bn | 133.99bn | 3.08k | 38.75 | -- | 30.07 | 7.52 | 34.11 | 34.11 | 174.83 | -- | -- | -- | -- | 5,780,584.00 | -- | 13.20 | -- | 15.82 | 68.23 | 55.88 | 19.51 | 18.03 | -- | 45.32 | -- | 12.84 | 21.37 | 19.43 | 31.09 | 28.70 | 25.57 | 11.84 |
| Qingdao Haier Biomedical Co Ltd | 29.69bn | 3.36bn | 135.48bn | 2.81k | 40.07 | 2.39 | -- | 4.56 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| 4DMedical Ltd | 375.92m | -1.93bn | 137.69bn | -- | -- | 27.25 | -- | 366.27 | -0.0714 | -0.0714 | 0.0138 | 0.138 | 0.0545 | 0.4858 | 0.8787 | -- | -27.99 | -32.98 | -34.63 | -40.38 | 92.07 | 86.20 | -513.72 | -1,237.52 | 0.8383 | -- | 0.0629 | -- | 55.91 | 36.56 | 16.42 | -- | 3.07 | -- |
| Nakanishi Inc | 48.00bn | -1.42bn | 138.65bn | 2.18k | -- | 1.85 | 68.74 | 2.89 | -29.41 | -29.41 | 969.19 | 1,373.65 | 0.5098 | 1.39 | 8.47 | -- | -1.51 | 8.35 | -1.84 | 9.73 | 56.74 | 59.43 | -2.95 | 16.56 | 2.57 | -- | 0.1901 | 38.60 | 5.37 | 19.69 | -127.96 | -- | 34.84 | 12.47 |
| Xiangyu Medical Co Ltd | 10.15bn | 964.37m | 143.32bn | 2.34k | 142.59 | 5.39 | -- | 14.12 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 6.02bn | 685.64m | 144.28bn | 500.00 | 210.45 | 6.14 | -- | 23.98 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
Data as of Feb 18 2026. Currency figures normalised to Poly Medicure Ltd's reporting currency: Indian Rupee INR
14.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| quant Money Managers Ltd.as of 30 Jan 2026 | 4.62m | 4.56% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2025 | 2.04m | 2.02% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 31 Jan 2026 | 1.77m | 1.75% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.34m | 1.32% |
| SBI Funds Management Ltd.as of 31 Jan 2026 | 1.23m | 1.21% |
| WhiteOak Capital Asset Management Ltd.as of 31 Dec 2025 | 924.91k | 0.91% |
| Wasatch Advisors LPas of 31 Dec 2025 | 721.05k | 0.71% |
| Abrdn Asia Ltd.as of 12 Feb 2026 | 685.47k | 0.68% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 509.34k | 0.50% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 408.46k | 0.40% |
More ▼
Data from 31 Dec 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
